Diego Based Heron News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Heron Therapeutics’ combo drug for post-surgical pain wins FDA nod on third try
Heron Therapeutics’ combo drug for post-surgical pain wins FDA nod on third try
Heron Therapeutics is positioning its drug, Zynrelef, as a way to help patients avoid addictive opioid painkillers following surgery. The extended-release formulation offers analgesic effects over 72 hours when postsurgical pain is most severe and more likely to require pain management medication.
Shares0
 
The FDA has approved a Heron Therapeutics combination drug developed to treat postsurgical pain and help patients avoid the need for opioid painkillers, a regulatory decision that comes after the agency twice turned down applications from the biotech. ....

Roy Soto , Enterprise Associates , European Medicines Agency , Beaumont Health System , Heron Therapeutics , Diego Based Heron , California Based Allay , Foundry Incubator , Lightstone Venture Singapore , New Enterprise , Lightstone Ventures , Brandon Capital Partners , Weight Loss , Medical Devices , Healthcare Innovation , Medcity News , Medcity News , San Francisco , Life Sciences , Rock Health , Startup Advice , Startup Funding , Patient Monitoring System , Otion Sensors , Healthcare It , Foodborne Pathogens ,